Synthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.

VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS

3D- QSAR, ADMET, and Molecular Docking Studies for Designing New 1,3,5-Triazine Derivatives as Anticancer Agents

Synthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR

Theoretical Drug Design, Molecular Docking And ADME Study Of New 1,3,4-Oxadiazole Derivatives: Promising Anticancer Agents Against Both Breast And Lung Cancers

Molecular Docking, Synthesis and ADME Studies of New Pyrazoline Derivatives as Potential Anticancer Agents

Molecular Docking and DFT Study of Synthesized Oxazine Derivatives

Synthesis, Biological Evaluation and Molecular Docking Studies of Newly Synthesized 4- Amino Quinazoline Derivatives as Potential Multitarget Anticancer Agents.

Synthesis of New Quinoxaline Pharmacophores as Antitumor Agents on MCF-7 breast cancer cells

Quinoxaline Derivatives Anti-Cancer Activities Through Protein Kinases Inhibition: A review